Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (301-310 of 311) with videos related to

Pageof 32
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 17, 2022
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysisMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
The European Respiratory Journal|November 5, 2021
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertensionMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
Ebiomedicine|October 7, 2022
The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodellingMaximilian Ackermann, Jan C Kamp, Christopher Werlein, et al.
Rheumatology (Oxford, England)|July 18, 2023
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysisOliver Distler, Christian Ofner, Dörte Huscher, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 4, 2022
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisStephan Rosenkranz, Christine Pausch, John G Coghlan, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Cardiovascular Diagnosis and Therapy|January 24, 2022
Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD RegistryAnn-Sophie Kaemmerer, Matthias Gorenflo, Dörte Huscher, et al.
Science Advances|May 8, 2026
The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosisJannik Ruwisch, Aurélie Cazes, Lena M Leiber, et al.
Pageof 32

Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 17, 2022
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysisMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
The European Respiratory Journal|November 5, 2021
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertensionMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
Ebiomedicine|October 7, 2022
The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodellingMaximilian Ackermann, Jan C Kamp, Christopher Werlein, et al.
Rheumatology (Oxford, England)|July 18, 2023
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysisOliver Distler, Christian Ofner, Dörte Huscher, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 4, 2022
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisStephan Rosenkranz, Christine Pausch, John G Coghlan, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Cardiovascular Diagnosis and Therapy|January 24, 2022
Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD RegistryAnn-Sophie Kaemmerer, Matthias Gorenflo, Dörte Huscher, et al.
Science Advances|May 8, 2026
The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosisJannik Ruwisch, Aurélie Cazes, Lena M Leiber, et al.
Pageof 32